Team:Johns Hopkins-Software/BiobrickAnalysis
From 2012.igem.org
(Difference between revisions)
Line 10: | Line 10: | ||
<br><br> | <br><br> | ||
When creating AutoPlasmid, we recognized the need for a streamline, automated method of annotating sequences in the field of synthetic biology, since the hand-annotated sequences are likely to have errors, and even with many eyes, it may still be difficult to spot errors in annotations. | When creating AutoPlasmid, we recognized the need for a streamline, automated method of annotating sequences in the field of synthetic biology, since the hand-annotated sequences are likely to have errors, and even with many eyes, it may still be difficult to spot errors in annotations. | ||
- | The registry of standard parts currently has over 20,000 parts; roughly 7,000 of them are categorized as available, 11,000 are planning, 1,500 have been deleted, and the rest are either categorized as unavailable, missing, or informational. New biobrick parts are characterized every year, and are hand-annotated, which often lead to errors in characterizing the sequence. To this end, we used AutoPlasmid’s annotation capabilities to check over the annotations made in all of the | + | The registry of standard parts currently has over 20,000 parts; roughly 7,000 of them are categorized as available, 11,000 are planning, 1,500 have been deleted, and the rest are either categorized as unavailable, missing, or informational. New biobrick parts are characterized every year, and are hand-annotated, which often lead to errors in characterizing the sequence. To this end, we used AutoPlasmid’s annotation capabilities to check over the annotations made in all of the <a href="http://partsregistry.org/Registry_API" biobricks</a> in the Registry of Standard Parts (as of September 1, 2012). |
<br><br> | <br><br> |
Revision as of 06:27, 3 October 2012